Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium Article

Chang, Susan M, Lamborn, Kathleen R, Kuhn, John G et al. (2008). Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium . NEURO-ONCOLOGY, 10(4), 631-642. 10.1215/15228517-2008-021

Open Access

cited authors

  • Chang, Susan M; Lamborn, Kathleen R; Kuhn, John G; Yung, WK Alfred; Gilbert, Mark R; Wen, Patrick Y; Fine, Howard A; Mehta, Minesh P; DeAngelis, Lisa M; Lieberman, Frank S; Cloughesy, Timothy F; Robins, H Ian; Abrey, Lauren E; Prados, Michael D

sustainable development goals

authors

publication date

  • August 1, 2008

webpage

published in

keywords

  • ANTICANCER THERAPY
  • ANTIEPILEPTIC DRUGS
  • CANCER
  • Clinical Neurology
  • DRUG DEVELOPMENT
  • GLIOBLASTOMA-MULTIFORME
  • GROWTH-FACTOR RECEPTOR
  • IRINOTECAN CPT-11
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • North American Brain Tumor Consortium
  • Oncology
  • PHASE-II TRIAL
  • RECURRENT MALIGNANT GLIOMA
  • Science & Technology
  • TASK-FORCE
  • brain tumor
  • clinical trials
  • targeted therapies

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 631

end page

  • 642

volume

  • 10

issue

  • 4